| 1 |
Minsky BD. Rectal cancer: is 'watch and wait’ a safe option for rectal cancer?[J]. Nat Rev Gastroenterol Hepatol, 2013, 10(12): 698-700.
|
| 2 |
Sauer R,Becker H,Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer[J]. N Engl J Med, 2004, 351(17): 1731-1740.
|
| 3 |
Collette L,Bosset JF,den Dulk M, et al. Patients with curative re-section of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluoroura-cil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Cancer Radiation Oncology Group[J]. J Clin Oncol, 2007, 25(28): 4379-4386.
|
| 4 |
Chau I,Brown G,Cunningham D, et al. Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer[J]. J Clin Oncol, 2006, 24(4): 668-674.
|
| 5 |
Habr-Gama A,Perez RO,São Julião GP, et al. Nonoperative ap-proaches to rectal cancer: a critical evaluation[J]. Semin Radiat Oncol, 2011, 21(3): 234-239.
|
| 6 |
Yu SK,Brown G,Heald RJ. Deferral of rectal surgery following a continued response to preoperative chemoradiotherapy (Watch and Wait) study: a phase Ⅱ multicenter study in the United King-dom [J]. J Clin Oncol, 2011, 29(Suppl 4): abstract 489.
|
| 7 |
Habr-Gama A,Perez RO,Nadalin W, et al. Operative versus non-operative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results[J]. Ann Surg, 2004, 240(4): 711-717; discussion 717-718.
|
| 8 |
Habr-Gama A,Perez RO,Proscurshim I, et al. Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy[J]. J Gastro-intest Surg, 2006, 10(10): 1319-1328.
|
| 9 |
Maas M,Beets-Tan RG,Lambregts DM, et al. Wait-and-see poli-cy for clinical complete responders after chemoradiation for rectal cancer[J]. J Clin Oncol, 2011, 29(35): 4633-4640.
|
| 10 |
Dalton RS,Velineni R,Osborne ME, et al. A single-centre experi-ence of chemoradiotherapy for rectal cancer: is there potential for nonoperative management?[J]. Colorectal Dis, 2012, 14(5): 567-571.
|
| 11 |
Smith JD,Ruby JA,Goodman KA, et al. Nonoperative manage-ment of rectal cancer with complete clinical response after neoad-juvant therapy[J]. Ann Surg, 2012, 256(6): 965-972.
|
| 12 |
Smith RK,Fry RD,Mahmoud NN, et al. Surveillance after neoad-juvant therapy in advanced rectal cancer with complete clinical re-sponse can have comparable outcomes to total mesorectal excision[J]. Int J Colorectal Dis, 2015, 30(6): 769-774.
|
| 13 |
Araujo RO,Valadão M,Borges D, et al. Nonoperative management of rectal cancer after chemoradiation opposed to resection after complete clinical response. A comparative study[J]. Eur J Surg On-col, 2015, 41(11): 1456-1463.
|
| 14 |
Appelt AL,Pløen J,Harling H, et al. High-dose chemoradiothera-py and watchful waiting for distal rectal cancer: a prospective ob-servational study[J]. Lancet Oncol, 2015, 16(8): 919-927.
|
| 15 |
Ayloor SR,Kondaveeti SS,Jayanand SB, et al. Complete clinical response to neoadjuvant chemoradiation in rectal cancers: can sur-gery be avoided?[J]. Hepatogastroenterology, 2013, 60(123): 410-414.
|
| 16 |
Li J,Liu H,Yin J, et al. Wait-and-see or radical surgery for rectal cancer patients with a clinical complete response after neoadju-vant chemoradiotherapy: a cohort study[J]. Oncotarget, 2015, 6(39): 42354-42361.
|
| 17 |
Read TE,Andujar JE,Caushaj PF, et al. Neoadjuvant therapy for rectal cancer: histologic response of the primary tumor predicts nodal status[J]. Dis Colon Rectum, 2004, 47(6): 825-831.
|
| 18 |
Habr-Gama A,de Souza PM,Ribeiro U, et al. Low rectal cancer: impact of radiation and chemotherapy on surgical treatment[J]. Dis Colon Rectum, 1998, 41(9): 1087-1096.
|
| 19 |
Habr-Gama A,Vianna MR,São Julião GP, et al. Management of adenomas within the area of rectal cancer that develop complete pathological response[J]. Int J Colorectal Dis, 2015, 30(9): 1285-1287.
|
| 20 |
Moore HG,Gittleman AE,Minsky BD, et al. Rate of pathologic complete response with increased interval between preoperative combined modality therapy and rectal cancer resection[J]. Dis Co-lon Rectum, 2004, 47(3): 279-286.
|
| 21 |
Kalady MF,de Campos-Lobato LF,Stocchi L, et al. Predictive fac-tors of pathologic complete response after neoadjuvant chemoradia-tion for rectal cancer[J]. Ann Surg, 2009, 250(4): 582-589.
|
| 22 |
Sloothaak DA,Geijsen DE,van Leersum NJ, et al. Optimal time interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer[J]. Br J Surg, 2013,100(7): 933-939.
|
| 23 |
Habr-Gama A,Perez RO,Wynn G, et al. Complete clinical re-sponse after neoadjuvant chemoradiation therapy for distal rectal cancer: characterization of clinical and endoscopic findings for standardization[J]. Dis Colon Rectum, 2010, 53(12): 1692-1698.
|
| 24 |
Patel PM,Harris K,Huerta S. Clinical and molecular diagnosis of pathologic complete response in rectal cancer[J]. Expert Rev Mol Diagn, 2015, 15(11): 1505-1516.
|
| 25 |
Park CH,Kim HC,Cho YB, et al. Predicting tumor response after preoperative chemoradiation using clinical parameters in rectal cancer[J]. World J Gastroenterol, 2011, 17(48): 5310-5316.
|
| 26 |
Das P,Skibber JM,Rodriguez-Bigas MA, et al. Predictors of tu-mor response and downstaging in patients who receive preopera-tive chemoradiation for rectal cancer[J]. Cancer, 2007, 109(9): 1750-1755.
|
| 27 |
Hiotis SP,Weber SM,Cohen AM, et al. Assessing the predictive value of clinical complete response to neoadjuvant therapy for rec-tal cancer: an analysis of 488 patients[J]. J Am Coll Surg, 2002, 194(2): 131-135; discussion 135-136.
|
| 28 |
Perez RO,São Julião GP,Habr-Gama A, et al. The role of carcin-oembriogenic antigen in predicting response and survival to neoad-juvant chemoradiotherapy for distal rectal cancer[J]. Dis Colon Rectum, 2009, 52(6): 1137-1143.
|
| 29 |
Yang TJ,Goodman KA. Predicting complete response: is there a role for non-operative management of rectal cancer?[J]. J Gastroin-test Oncol, 2015, 6(2): 241-246.
|
| 30 |
Russo AL,Ryan DP,Borger DR, et al. Mutational and clinical pre-dictors of pathologic complete response in the treatment of locally advanced rectal cancer[J]. J Gastrointest Cancer, 2014, 45(1): 34-39.
|
| 31 |
Dresen RC,Beets GL,Rutten HJ, et al. Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation thera-py with concomitant chemotherapy. Part I. Are we able to predict tumor confined to the rectal wall?[J]. Radiology, 2009, 252(1): 71-80.
|
| 32 |
Beets-Tan RG,Beets GL. MRI for assessing and predicting re-sponse to neoadjuvant treatment in rectal cancer[J]. Nat Rev Gas-troenterol Hepatol, 2014, 11(8): 480-488.
|
| 33 |
Perez RO,Habr-Gama A,Gama-Rodrigues J, et al. Accuracy of positron emission tomography/computed tomography and clinical assessment in the detection of complete rectal tumor regression af-ter neoadjuvant chemoradiation: long-term results of a prospective trial (National Clinical Trial 00254683)[J]. Cancer, 2012, 118(14): 3501-3511.
|
| 34 |
Habr-Gama A,Gama-Rodrigues J,Perez RO, et al. Late assess-ment of local control by PET in patients with distal rectal cancer managed non-operatively after complete tumor regression follow-ing neoadjuvant chemoradiation[J]. Tech Coloproctol, 2008, 12(1): 74-76.
|
| 35 |
Perez RO,Habr-Gama a,São Julião GP, et al. transanal endoscop-ic microsurgery (tem) following neoadjuvant chemoradiation for rectal cancer: outcomes of salvage resection for local recurrence[J]. Ann Surg Oncol, 2016, 23(4): 1143-1148.
|
| 36 |
Pastor C,Subtil JC,Sola J, et al. Accuracy of endoscopic ultra-sound to assess tumor response after neoadjuvant treatment in rec-tal cancer: can we trust the findings?[J]. Dis Colon Rectum, 2011, 54(9): 1141-1146.
|